Assessing Astronics (ATRO) Valuation After Analyst Upgrades And A Push Toward Its 52-Week High
Astronics Corporation ATRO | 0.00 |
Why Astronics Stock Is Back in Focus
Astronics (ATRO) is back on investors’ radar after a strong price trend, supported by positive earnings estimate revisions and favorable analyst opinions. The stock is now trading close to its 52-week high.
The recent momentum is clear, with a 7-day share price return of 9.17% and a year to date share price return of 37.70%. The 1-year total shareholder return is very large, and the 3-year total shareholder return is roughly 4x, pointing to strong longer term gains that recent moves are building on rather than reversing.
If Astronics has caught your attention and you want to see what else is moving, this is a good time to broaden your search with 18 top founder-led companies
With Astronics now near its 52 week high, analysts broadly positive, and the stock still showing a roughly 9% intrinsic discount, the key question is clear: Is there real upside left here, or is future growth already priced in?
Most Popular Narrative: 27.4% Overvalued
The most followed narrative pegs Astronics' fair value at $61.18, which sits well below the recent price of $77.95 and creates a clear valuation tension for investors to unpack.
Coverage notes call out volume, penetration, and new contract tailwinds across aerospace and defense, with the potential for double digit revenue growth and over 40 percent incremental margins. This combination is seen as attractive for growth at a reasonable price investors and supportive of the thesis that the stock could significantly outperform, potentially even doubling over the next few years if the plan is executed.
Want to see what is baked into that $61 fair value marker? The narrative leans heavily on rapid earnings compounding, firmer margins, and a richer earnings multiple. Curious which specific growth path and profitability targets need to line up for that view to hold?
Result: Fair Value of $61.18 (OVERVALUED)
However, that upside view can unravel quickly if tariff costs stay elevated, or if Test Systems execution issues and legal disputes start to bite harder than expected.
Another Take: Cash Flows Point the Other Way
While the most popular narrative sees Astronics as 27.4% overvalued at around $77.95, the SWS DCF model points to a fair value of $85.96, implying the stock is trading at roughly a 9.3% discount. Two valuation tools, two different signals. Which one matches your expectations for cash generation and risk?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Astronics for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
The mix of optimism and concern around Astronics is clear, so this is a moment to move quickly and test the numbers yourself. To weigh the upside potential against the key issues on your own terms, start by reviewing the 3 key rewards and 2 important warning signs
Ready to hunt for your next opportunity?
If Astronics has sharpened your focus, do not stop here. Broaden your watchlist now or you risk missing other compelling setups hiding in plain sight.
- Target potential mispricing by scanning companies that look attractively valued using the 51 high quality undervalued stocks.
- Prioritize resilience by filtering for companies with sturdier finances through the solid balance sheet and fundamentals stocks screener (44 results).
- Spot opportunities that others may be overlooking by checking the screener containing 23 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
